#VisualAbstract: Doxycycline Post-Exposure Prophylaxis Effectively Prevents Bacterial Sexually Transmitted Infections

Click here to read this study in the Lancet.

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Nuzolvence (Zoliflodacin) first oral Gonorrhea treatment shows non-inferior cure rates

2 Minute Medicine: Pharma Roundup – New oral gonorrhea antibiotic Nuzolvence (zoliflodacin), late‑December cardiovascular and oncology drug approvals, first targeted complement inhibitor therapy for HSCT‑TMA (Yartemlea), and antibody‑drug conjugate (ADC) safety concerns with ifinatamab deruxtecan (I‑DXd) [January 2026]

Doxycycline in Pneumonia: Coverage, Effectiveness, and Limitations

#VisualAbstract: Doxycycline Post-Exposure Prophylaxis Effectively Prevents Bacterial Sexually Transmitted Infections

Nuzolvence (Zoliflodacin) first oral Gonorrhea treatment shows non-inferior cure rates

Doxycycline in Pneumonia: Coverage, Effectiveness, and Limitations

Automated insulin delivery improves glycemic control over continuous glucose monitoring

Intensive blood pressure control reduces major cardiovascular event risk in type 2 diabetes patients

RelatedReports

Nuzolvence (Zoliflodacin) first oral Gonorrhea treatment shows non-inferior cure rates

Doxycycline in Pneumonia: Coverage, Effectiveness, and Limitations

Oral gepotidacin is non-inferior to standard therapy for uncomplicated urogenital gonorrhea

Intensive blood pressure control reduces major cardiovascular event risk in type 2 diabetes patients

Tezepelumab alleviates symptoms in severe chronic rhinosinusitis with nasal polyps

Artificial intelligence demonstrates non-inferiority to radiologists at tuberculosis detection within a population with a high-disease burden

Recent Reports